लोड हो रहा है...

Multifaceted role of BTLA in the control of CD8(+) T cell fate after antigen encounter

PURPOSE: Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes (TIL) has shown an overall clinical response rate 40–50% in metastatic melanoma patients. BTLA (B-and-T lymphocyte attenuator) expression on transferred CD8(+) TIL was associated with better clinical outcome. The suppre...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Clin Cancer Res
मुख्य लेखकों: Ritthipichai, Krit, Haymaker, Cara L., Martinez, Melisa, Aschenbrenner, Andrew, Yi, Xiaohui, Zhang, Minying, Kale, Charuta, Vence, Luis M., Roszik, Jason, Hailemichael, Yared, Overwijk, Willem W., Varadarajan, Navin, Nurieva, Roza, Radvanyi, Laszlo G., Hwu, Patrick, Bernatchez, Chantale
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2017
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5748156/
https://ncbi.nlm.nih.gov/pubmed/28754817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-1217
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!